Midostaurin: an emerging treatment for acute myeloid leukemia patients

Article Properties
Cite
Lazarus, Hillard, and Molly Miller. “Midostaurin: An Emerging Treatment for Acute Myeloid Leukemia Patients”. Journal of Blood Medicine, 2016, p. 73, https://doi.org/10.2147/jbm.s100283.
Lazarus, H., & Miller, M. (2016). Midostaurin: an emerging treatment for acute myeloid leukemia patients. Journal of Blood Medicine, 73. https://doi.org/10.2147/jbm.s100283
Lazarus H, Miller M. Midostaurin: an emerging treatment for acute myeloid leukemia patients. Journal of Blood Medicine. 2016;:73.
Journal Category
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the blood and blood-forming organs
Citations
Title Journal Journal Categories Citations Publication Date
Midostaurin and emerging FLT3 inhibitors for the treatment of adults with newly diagnosed acute myeloid leukemia with the FLT3 mutation Expert Review of Precision Medicine and Drug Development
  • Medicine: Therapeutics. Pharmacology
 1 2017
Citations Analysis
Category Category Repetition
Medicine: Therapeutics. Pharmacology1
The category Medicine: Therapeutics. Pharmacology 1 is the most commonly referenced area in studies that cite this article.